Trial Profile
Pharmacokinetics and tolerability of Delafloxacin in subjects with varying degrees of renal function
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Apr 2018
Price :
$35
*
At a glance
- Drugs Delafloxacin (Primary) ; Delafloxacin (Primary)
- Indications Community-acquired pneumonia; Skin and soft tissue infections; Urinary tract infections
- Focus Adverse reactions; Pharmacokinetics
- 26 Mar 2018 Results (n=44) assessing pharmacokinetics and tolerability of Delafloxacin in subjects with varying degrees of renal function, were published in the Journal of Clinical Pharmacology.
- 14 Mar 2018 Results assessing pharmacokinetics between healthy subjects and subjects with end-stage renal disease (n=19) published in the Journal of Clinical Pharmacology
- 02 Jan 2018 New trial record